Hudson Valley Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Hold
11,000
0.26% 79
2026
Q1
$2.47M Hold
11,000
0.32% 74
2025
Q4
$2.65M Hold
11,000
0.29% 76
2025
Q3
$3.01M Hold
11,000
0.31% 78
2025
Q2
$2.84M Hold
11,000
0.31% 79
2025
Q1
$2.46M Hold
11,000
0.29% 72
2024
Q4
$2.52M Hold
11,000
0.28% 75
2024
Q3
$2.69M Hold
11,000
0.3% 73
2024
Q2
$1.9M Hold
11,000
0.25% 81
2024
Q1
$2.18M Hold
11,000
0.26% 78
2023
Q4
$1.9M Sell
11,000
-18
-0.2% -$2.77K 0.26% 82
2023
Q3
$1.63M Hold
11,018
0.23% 85
2023
Q2
$2.41M Hold
11,018
0.33% 80
2023
Q1
$2.41M Hold
11,018
0.34% 82
2022
Q4
$2.29M Hold
11,018
0.35% 82
2022
Q3
$2.4M Hold
11,018
0.39% 71
2022
Q2
$2.31M Buy
11,018
+18
+0.2% +$3.83K 0.36% 76
2022
Q1
$2.67M Hold
11,000
0.36% 77
2021
Q4
$2.87M Hold
11,000
0.45% 56
2021
Q3
$2.9M Hold
11,000
0.5% 54
2021
Q2
$2.71M Sell
11,000
-9,098
-45% -$1.91M 0.47% 57
2021
Q1
$3.04M Sell
20,098
-328
-2% -$65.8K 0.54% 54
2020
Q4
$3.2M Sell
20,426
-5,354
-21% -$1.07M 0.61% 50
2020
Q3
$2.96M Sell
25,780
-608
-2% -$112K 0.64% 48
2020
Q2
$3.04M Sell
26,388
-3,791
-13% -$620K 0.71% 46
2020
Q1
$2.63M Sell
30,179
-14,398
-32% -$2.29M 0.73% 45
2019
Q4
$6.48M Buy
44,577
+223
+0.5% +$32.1K 1.38% 19
2019
Q3
$5.46M Sell
44,354
-903
-2% -$118K 1.27% 22
2019
Q2
$5.51M Buy
45,257
+183
+0.4% +$20.3K 1.28% 23
2019
Q1
$4.91M Sell
45,074
-4,270
-9% -$441K 1.19% 26
2018
Q4
$5.22M Sell
49,344
-13,429
-21% -$1.44M 1.2% 25
2018
Q3
$7.8M Buy
62,773
+1,799
+3% +$197K 1.81% 14
2018
Q2
$6.32M Buy
60,974
+1,301
+2% +$132K 1.55% 16
2018
Q1
$6.54M Buy
59,673
+1,544
+3% +$146K 1.65% 16
2017
Q4
$6.04M Buy
58,129
+365
+0.6% +$30.2K 1.49% 16
2017
Q3
$5.78M Sell
57,764
-800
-1% -$61.2K 1.5% 15
2017
Q2
$5.55M Buy
58,564
+245
+0.4% +$17.5K 1.53% 13
2017
Q1
$5.01M Sell
58,319
-850
-1% -$58.7K 1.4% 21
2016
Q4
$4.29M Buy
59,169
+1,169
+2% +$71.6K 1.26% 22
2016
Q3
$4.06M Buy
58,000
+609
+1% +$40.5K 1.26% 23
2016
Q2
$3.74M Sell
57,391
-6,744
-11% -$398K 1.2% 26
2016
Q1
$4.32M Buy
64,135
+7,380
+13% +$418K 1.4% 21
2015
Q4
$3.89M Sell
56,755
-7,605
-12% -$429K 1.21% 27
2015
Q3
$3.83M Buy
64,360
+9,210
+17% +$496K 1.24% 26
2015
Q2
$3.22M Buy
55,150
+35,150
+176% +$2.22M 1.01% 36
2015
Q1
$1.44M Buy
+20,000
New +$1.3M 0.49% 59
2013
Q3
Sell
-9,000
Closed -$406K 125
2013
Q2
$406K Buy
+9,000
New +$427K 0.19% 84

Other funds holding RMD

Hudson Valley Investment Advisors's RMD Position: Q2 2026 in Review

Hudson Valley Investment Advisors held its ResMed (RMD) position steady in Q2 2026 at 11,000 shares worth $2.14M. The position accounts for 0.26% of the portfolio, ranked #79.

Hudson Valley Investment Advisors first reported a position in RMD in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.8M in Q3 2018. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Hudson Valley Investment Advisors held 11,000 shares of ResMed worth $2.14M as of Q2 2026.
  • Hudson Valley Investment Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.26% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #79 holding.
  • Hudson Valley Investment Advisors first reported a position in ResMed in Q2 2013 and has held it in 47 quarters since.
  • Hudson Valley Investment Advisors's ResMed position peaked at $7.8M in Q3 2018.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.